Meta-Analysis of Gene Expression Signatures Defining the Epithelial to Mesenchymal Transition during Cancer Progression

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Gröger, Christian J ^a   Grubinger, Markus ^a   Waldhör, Thomas ^b   Vierlinger, Klemens ^c   Mikulits, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c AIT AUSTRIAN INSTITUTE OF TECHNOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER GROWTH; CELL DENSITY; CELL MIGRATION; CLUSTER ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE CLUSTER; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MATHEMATICAL COMPUTING; NUCLEOTIDE SEQUENCE; PHENOTYPE; SIGNAL TRANSDUCTION; UPREGULATION;

CLUSTER ANALYSIS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS;

EID: 84870950913     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051136     Document Type: Article

References (70)

1. Hay ED, (1995) An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 154: 8-20.
2. Hay ED, (2005) The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233: 706-720.
3. van Zijl F, Krupitza G, Mikulits W, (2011) Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res 728: 23-34.
4. Friedl P, Alexander S, (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147: 992-1009.
5. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
6. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
7. Loboda A, Nebozhyn MV, Watters JW, Buser CA, Shaw PM, et al. (2011) EMT is the dominant program in human colon cancer. BMC Med Genomics 4: 9.
8. Tobin NP, Sims AH, Lundgren KL, Lehn S, Landberg G, (2011) Cyclin D1, Id1 and EMT in breast cancer. BMC Cancer 11: 417.
9. Huang da W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
10. Rhee SY, Wood V, Dolinski K, Draghici S, (2008) Use and misuse of the gene ontology annotations. Nat Rev Genet 9: 509-515.
11. Lascorz J, Chen B, Hemminki K, Forsti A, (2011) Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studies. PLoS One 6: e18867.
12. Takahashi E, Nagano O, Ishimoto T, Yae T, Suzuki Y, et al. (2010) Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction. J Biol Chem 285: 4060-4073.
13. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, et al. (2010) Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 107: 15449-15454.
14. Yilmaz M, Christofori G, (2010) Mechanisms of motility in metastasizing cells. Mol Cancer Res 8: 629-642.
15. Zeisberg M, Neilson EG, (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437.
16. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
17. Raponi M, Zhang Y, Yu J, Chen G, Lee G, et al. (2006) Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 66: 7466-7472.
18. Hess KR, Anderson K, Symmans WF, Valero V, Ibrahim N, et al. (2006) Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol 24: 4236-4244.
19. Hwang WL, Yang MH, Tsai ML, Lan HY, Su SH, et al. (2011) SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 141: 279-291, 291 e271-275.
20. Micalizzi DS, Christensen KL, Jedlicka P, Coletta RD, Baron AE, et al. (2009) The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. J Clin Invest 119: 2678-2690.
21. Baniwal SK, Khalid O, Gabet Y, Shah RR, Purcell DJ, et al. (2010) Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis. Mol Cancer 9: 258.
22. Micalizzi DS, Wang CA, Farabaugh SM, Schiemann WP, Ford HL, (2010) Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth. Cancer Res 70: 10371-10380.
23. Farabaugh SM, Micalizzi DS, Jedlicka P, Zhao R, Ford HL, (2012) Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-beta signaling, epithelial-mesenchymal transition, and cancer stem cell properties. Oncogene 31: 552-562.
24. Lee KS, Hong SH, Bae SC, (2002) Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21: 7156-7163.
25. Chimge NO, Baniwal SK, Little GH, Chen YB, Kahn M, et al. (2011) Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2. Breast Cancer Res 13: R127.
26. van Zijl F, Mall S, Machat G, Pirker C, Zeillinger R, et al. (2011) A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progression. Mol Cancer Ther 10: 850-860.
27. Ip YT, Park RE, Kosman D, Yazdanbakhsh K, Levine M, (1992) dorsal-twist interactions establish snail expression in the presumptive mesoderm of the Drosophila embryo. Genes Dev 6: 1518-1530.
28. Ke XS, Li WC, Hovland R, Qu Y, Liu RH, et al. (2011) Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. Exp Cell Res 317: 234-247.
29. Ohashi S, Natsuizaka M, Naganuma S, Kagawa S, Kimura S, et al. (2011) A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res 71: 6836-6847.
30. Zoltan-Jones A, Huang L, Ghatak S, Toole BP, (2003) Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem 278: 45801-45810.
31. Ren D, Minami Y, Nishita M, (2011) Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition. Genes Cells 16: 304-315.
32. Kumar S, Park SH, Cieply B, Schupp J, Killiam E, et al. (2011) A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition. Mol Cell Biol 31: 4036-4051.
33. Chen LM, Verity NJ, Chai KX, (2009) Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT). BMC Cancer 9: 377.
34. Sung YM, Xu X, Sun J, Mueller D, Sentissi K, et al. (2009) Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo. PLoS One 4: e7445.
35. Talieri M, Alexopoulou DK, Scorilas A, Kypraios D, Arnogiannaki N, et al. (2011) Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer. Tumour Biol 32: 737-744.
36. Seibold S, Rudroff C, Weber M, Galle J, Wanner C, et al. (2003) Identification of a new tumor suppressor gene located at chromosome 8p21.3-22. FASEB J 17: 1180-1182.
37. Mandal S, Abebe F, Chaudhary J, (2011) 2′-5′ oligoadenylate synthetase 1 polymorphism is associated with prostate cancer. Cancer 117: 5509-5518.
38. Chou RH, Wen HC, Liang WG, Lin SC, Yuan HW, et al. (2012) Suppression of the invasion and migration of cancer cells by SERPINB family genes and their derived peptides. Oncol Rep 27: 238-245.
39. Choi YL, Bocanegra M, Kwon MJ, Shin YK, Nam SJ, et al. (2010) LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer. Cancer Res 70: 2296-2306.
40. Yamamoto H, Okumura K, Toshima S, Mukaisho K, Sugihara H, et al. (2009) FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues. Biol Pharm Bull 32: 1148-1154.
41. Yamamoto H, Mukaisho K, Sugihara H, Hattori T, Asano S, (2011) Down-regulation of FXYD3 is induced by transforming growth factor-beta signaling via ZEB1/deltaEF1 in human mammary epithelial cells. Biol Pharm Bull 34: 324-329.
42. Diamandis EP, Goodglick L, Planque C, Thornquist MD, (2011) Pentraxin-3 is a novel biomarker of lung carcinoma. Clin Cancer Res 17: 2395-2399.
43. Rouleau C, Roy A, St Martin T, Dufault MR, Boutin P, et al. (2006) Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function. Mol Cancer Ther 5: 219-229.
44. Kuk C, Gunawardana CG, Soosaipillai A, Kobayashi H, Li L, et al. (2010) Nidogen-2: a new serum biomarker for ovarian cancer. Clin Biochem 43: 355-361.
45. Marr HS, Edgell CJ, (2003) Testican-1 inhibits attachment of Neuro-2a cells. Matrix Biol 22: 259-266.
46. Nakada M, Yamada A, Takino T, Miyamori H, Takahashi T, et al. (2001) Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. Cancer Res 61: 8896-8902.
47. Junnila S, Kokkola A, Mizuguchi T, Hirata K, Karjalainen-Lindsberg ML, et al. (2010) Gene expression analysis identifies over-expression of CXCL1, SPARC, SPP1, and SULF1 in gastric cancer. Genes Chromosomes Cancer 49: 28-39.
48. Yue X, Li X, Nguyen HT, Chin DR, Sullivan DE, et al. (2008) Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo. J Biol Chem 283: 20397-20407.
49. Sun W, Wei X, Kesavan K, Garrington TP, Fan R, et al. (2003) MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src. Mol Cell Biol 23: 2298-2308.
50. Wen J, Nikitakis NG, Chaisuparat R, Greenwell-Wild T, Gliozzi M, et al. (2011) Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma. Am J Pathol 178: 2866-2878.
51. Amiano NO, Costa MJ, Reiteri RM, Payes C, Guerrieri D, et al. (2012) Antitumor effect of SLPI on mammary but not colon tumor growth. J Cell Physiol.
52. Choi BD, Jeong SJ, Wang G, Park JJ, Lim DS, et al. (2011) Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells. Int J Mol Med 28: 527-534.
53. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
54. R Development Core Team (2011) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
55. Warnes GR, Bolker B, Gorjanc G, Grothendieck G, Korosec A, et al. (2011) gdata: Various R programming tools for data manipulation. R package version 2.8.2. CRAN website. Available: http://CRAN.R-project.org/package=gdata. Accessed 2012 June 25.
56. Warnes GR, Bolker B, Bonebakker L, Gentleman R, Huber W, et al. (2011) gplots: Various R programming tools for plotting data. R package version 2.10.1. CRAN website. Available: http://CRAN.R-project.org/package=gplots. Accessed 2012 June 25.
57. Day A (2007) heatmap.plus: Heatmap with more sensible behavior. R package version 1.3. CRAN website. Available: http://CRAN.R-project.org/package=heatmap.plus. Accessed 2012 June 25.
58. Medina I, Carbonell J, Pulido L, Madeira SC, Goetz S, et al. (2010) Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 38: W210-213.
59. Zhang B, Kirov S, Snoddy J, (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33: W741-748.
60. Thernau T (2012) A Package for Survival Analysis in S. CRAN website. Available: http://CRAN.R-project.org/package=survival. Accessed 2012 June 25.
61. Andarawewa KL, Erickson AC, Chou WS, Costes SV, Gascard P, et al. (2007) Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition. Cancer Res 67: 8662-8670.
62. Tay PN, Tan P, Lan Y, Leung CH, Laban M, et al. (2010) Palladin, an actin-associated protein, is required for adherens junction formation and intercellular adhesion in HCT116 colorectal cancer cells. Int J Oncol 37: 909-926.
63. Drake JM, Strohbehn G, Bair TB, Moreland JG, Henry MD, (2009) ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells. Mol Biol Cell 20: 2207-2217.
64. Sartor MA, Mahavisno V, Keshamouni VG, Cavalcoli J, Wright Z, et al. (2010) ConceptGen: a gene set enrichment and gene set relation mapping tool. Bioinformatics 26: 456-463.
65. Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, et al. (2010) Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res 70: 968-978.
66. Hills CE, Willars GB, Brunskill NJ, (2010) Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways. Mol Endocrinol 24: 822-831.
67. Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, et al. (2011) TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model. PLoS One 6: e21650.
68. Maupin KA, Sinha A, Eugster E, Miller J, Ross J, et al. (2010) Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems. PLoS One 5: e13002.
69. Hesling C, Fattet L, Teyre G, Jury D, Gonzalo P, et al. (2011) Antagonistic regulation of EMT by TIF1gamma and Smad4 in mammary epithelial cells. EMBO Rep 12: 665-672.
70. Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF, (2011) Isolation and characterization of stem-like cells from a human ovarian cancer cell line. Mol Cell Biochem 363: 257-268.